| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 1 113-119, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
MR Stofega, CL Yu, J Wu and R Jove
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor 48109, USA.
Stimulation of mitogenic signaling pathways results in transient activation of the extracellular signal-regulated kinase (ERK) subfamily of mitogen-activated protein kinases (MAPK) in normal cells. We demonstrate here that activation of ERKs in response to serum or phorbol ester stimulation was markedly repressed in three different rodent fibroblast cell lines stably transformed by v-Src. Activation of the MAPK/ERK kinase (MEK) was also repressed in v-Src-transformed cells, indicating that the repression occurs upstream of ERK. Consistent with repression occurring predominantly at the level of MEK, the phosphatase inhibitor orthovanadate could restore ERK activation to a limited extent in some but not all v-Src-transformed cell lines. A similar repression of ERK activation was observed in v-Ras- and v-Raf-transformed cells. In addition, ERK activity was not constitutively elevated in exponentially growing cells transformed by v-Src, v-Ras, or v-Raf as compared with normal cells. These results establish that the ERK activation pathway is repressed in rodent fibroblasts stably transformed by viral oncoproteins that chronically stimulate receptor tyrosine kinase signaling pathways. Furthermore, our findings suggest that elevated ERK activity above basal levels is not required for maintaining cell transformation by these oncoproteins. Taken together, these results indicate that ERK signaling pathways are subject to negative feedback regulation upstream of ERK as a consequence of oncogenic transformation.
This article has been cited by other articles:
![]() |
M. V. Cespedes, F. J. Sancho, S. Guerrero, M. Parreno, I. Casanova, M. A. Pavon, E. Marcuello, M. Trias, M. Cascante, G. Capella, et al. K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12 Carcinogenesis, November 1, 2006; 27(11): 2190 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-T. Yang, K. Alexandropoulos, and J. Sap c-SRC Mediates Neurite Outgrowth through Recruitment of Crk to the Scaffolding Protein Sin/Efs without Altering the Kinetics of ERK Activation J. Biol. Chem., May 10, 2002; 277(20): 17406 - 17414. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Paasinen-Sohns, M. Kielosto, E. Kaariainen, T. Eloranta, A. Laine, O. A. Janne, M. J. Birrer, and E. Holtta c-Jun Activation-dependent Tumorigenic Transformation Induced Paradoxically by Overexpression or Block of S-Adenosylmethionine Decarboxylase J. Cell Biol., November 13, 2000; 151(4): 801 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rosenkranz, Y. Ikuno, F. L. Leong, R. A. Klinghoffer, S. Miyake, H. Band, and A. Kazlauskas Src Family Kinases Negatively Regulate Platelet-derived Growth Factor alpha Receptor-dependent Signaling and Disease Progression J. Biol. Chem., March 24, 2000; 275(13): 9620 - 9627. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Turkson, T. Bowman, J. Adnane, Y. Zhang, J. Y. Djeu, M. Sekharam, D. A. Frank, L. B. Holzman, J. Wu, S. Sebti, et al. Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein Mol. Cell. Biol., November 1, 1999; 19(11): 7519 - 7528. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Penuel and G. S. Martin Transformation by v-Src: Ras-MAPK and PI3K-mTOR Mediate Parallel Pathways Mol. Biol. Cell, June 1, 1999; 10(6): 1693 - 1703. [Abstract] [Full Text] |
||||
![]() |
H. Greulich and R. L. Erikson An Analysis of Mek1 Signaling in Cell Proliferation and Transformation J. Biol. Chem., May 22, 1998; 273(21): 13280 - 13288. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Turkson, T. Bowman, R. Garcia, E. Caldenhoven, R. P. De Groot, and R. Jove Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation Mol. Cell. Biol., May 1, 1998; 18(5): 2545 - 2552. [Abstract] [Full Text] |
||||
![]() |
M. A. Antonyak, D. K. Moscatello, and A. J. Wong Constitutive Activation of c-Jun N-terminal Kinase by a Mutant Epidermal Growth Factor Receptor J. Biol. Chem., January 30, 1998; 273(5): 2817 - 2822. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Moscatello, M. Holgado-Madruga, D. R. Emlet, R. B. Montgomery, and A. J. Wong Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor J. Biol. Chem., January 2, 1998; 273(1): 200 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Aftab, J. Kwan, and G. S. Martin Ras-independent transformation by v-Src PNAS, April 1, 1997; 94(7): 3028 - 3033. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |